Is a low omega-3 index associated with higher C-reactive protein (CRP)?

Extensive research indicates that a low omega-3 index—a measure of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in red blood cell membranes—is a reliable predictor of elevated systemic inflammation, particularly C-reactive protein (CRP).

Clinical evidence

Observational and intervention studies demonstrate a consistent inverse relationship between omega-3 status and inflammatory biomarkers.

• Correlation with CRP: Studies in diverse patient populations, including those with peripheral artery disease and systemic lupus erythematosus (SLE), show that individuals with a lower omega-3 index have significantly higher levels of circulating CRP.
• Metabolic Markers: Research involving plasma oxylipins reveals that lower levels of omega-3 derivatives are associated with poorer metabolic profiles and increased inflammatory markers, whereas higher omega-6 levels are often positively correlated with CRP.
• Intervention Efficacy: Clinical trials have shown that increasing omega-3 intake through supplementation effectively reduces CRP levels across various cardiometabolic conditions, confirming that the association is not merely observational but responsive to changes in status.

Mechanistic explanations

The biological link between omega-3 status and CRP is driven by the regulatory role these fatty acids play in immune signaling pathways.

• Transcription Factor Modulation: EPA and DHA act as ligands for the GPR120 (FFAR4) receptor and peroxisome proliferator-activated receptor alpha (PPARα). Activation of these pathways inhibits the activity of nuclear factor kappa-B (NF-κB), a primary driver of the inflammatory response.
• Cytokine Suppression: NF-κB inhibition leads to decreased production of pro-inflammatory cytokines, specifically interleukin-6 (IL-6). Because the liver produces CRP primarily in response to IL-6, a low omega-3 status effectively "removes the brakes" on this pathway, resulting in higher systemic CRP.
• Eicosanoid Switching: Omega-3s compete with arachidonic acid (an omega-6) for incorporation into cell membranes. When omega-3 levels are low, there is a higher production of pro-inflammatory eicosanoids (like PGE2 and LTB4) and a lower production of anti-inflammatory specialized pro-resolving mediators (SPMs).

Bottom line

A low omega-3 index is strongly associated with higher systemic inflammation markers like CRP. Maintaining a high omega-3 status helps suppress inflammatory signaling through NF-κB inhibition and the production of anti-inflammatory lipid mediators.